Article
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases.
Journal of gastroenterology and hepatology - 1 Feb 2011
Fabris Carlo, Vandelli Carmen, Toniutto Pierluigi, Minisini Rosalba, Colletta Cosimo, Falleti Edmondo, Smirne Carlo, Pirisi Mario
Abstract excerpt
BACKGROUND AND AIM: Carriage of the apolipoprotein E (Apo E) variants, E2, E3 and E4, affects cholesterol metabolism and may be involved in the persistence of hepatitis C virus (HCV) infection. Our aim was to verify whether carriage of specific Apo E variants modulates the course of hepatitis C. METHODS: We studied a cohort of 116 HCV-positive patients (49 male subjects) with persistently normal transaminases and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
